Vaccinex, Inc. (VCNX)
USD 1.0
(66.67%)
USD 1.0
(66.67%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -20.25 Million USD | -2.68% |
| 2022 | -19.72 Million USD | 15.11% |
| 2021 | -23.23 Million USD | 20.73% |
| 2020 | -29.3 Million USD | 8.45% |
| 2019 | -32.01 Million USD | -8.46% |
| 2018 | -29.51 Million USD | -57.66% |
| 2017 | -18.72 Million USD | -34.28% |
| 2016 | -13.94 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -3.89 Million USD | -17.49% |
| 2024 Q2 | -5.63 Million USD | -44.5% |
| 2023 FY | -20.25 Million USD | -2.68% |
| 2023 Q1 | -4.93 Million USD | 1.61% |
| 2023 Q4 | -3.31 Million USD | 32.47% |
| 2023 Q2 | -7.06 Million USD | -42.97% |
| 2023 Q3 | -4.91 Million USD | 30.42% |
| 2022 Q3 | -4.75 Million USD | 11.3% |
| 2022 FY | -19.72 Million USD | 15.11% |
| 2022 Q1 | -4.59 Million USD | 0.76% |
| 2022 Q2 | -5.36 Million USD | -16.73% |
| 2022 Q4 | -5.01 Million USD | -5.46% |
| 2021 Q2 | -5.96 Million USD | 9.2% |
| 2021 Q1 | -6.57 Million USD | -2.0% |
| 2021 FY | -23.23 Million USD | 20.73% |
| 2021 Q4 | -4.63 Million USD | 11.04% |
| 2021 Q3 | -5.2 Million USD | 12.78% |
| 2020 Q2 | -6.5 Million USD | 9.06% |
| 2020 Q1 | -7.14 Million USD | -13.01% |
| 2020 Q4 | -6.44 Million USD | 26.38% |
| 2020 FY | -29.3 Million USD | 8.45% |
| 2020 Q3 | -8.75 Million USD | -34.66% |
| 2019 Q2 | -8.82 Million USD | 2.64% |
| 2019 FY | -32.01 Million USD | -8.46% |
| 2019 Q4 | -6.32 Million USD | 17.22% |
| 2019 Q3 | -7.64 Million USD | 13.43% |
| 2019 Q1 | -9.06 Million USD | -7.31% |
| 2018 Q4 | -8.44 Million USD | -28.03% |
| 2018 FY | -29.51 Million USD | -57.66% |
| 2018 Q3 | -6.59 Million USD | 0.14% |
| 2018 Q2 | -6.6 Million USD | 15.95% |
| 2018 Q1 | -7.86 Million USD | -203.55% |
| 2017 Q1 | -5.71 Million USD | 0.0% |
| 2017 Q2 | -4.87 Million USD | 14.66% |
| 2017 Q3 | -5.53 Million USD | -13.47% |
| 2017 Q4 | -2.59 Million USD | 53.22% |
| 2017 FY | -18.72 Million USD | -34.28% |
| 2016 FY | -13.94 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| America Great Health | -761.42 Thousand USD | -2559.636% |
| Ampio Pharmaceuticals, Inc. | -8.63 Million USD | -134.604% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | 34.141% |
| Biora Therapeutics, Inc. | -124.11 Million USD | 83.684% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -25.955% |
| Better Therapeutics, Inc. | -39.76 Million USD | 49.067% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -7.341% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -10.192% |
| Gene Biotherapeutics, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | 43.45% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | 43.849% |
| Evelo Biosciences, Inc. | -114.52 Million USD | 82.318% |
| Evolutionary Genomics, Inc. | -2.24 Million USD | -800.741% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | 72.91% |
| Galera Therapeutics, Inc. | -59.08 Million USD | 65.724% |
| Innovation1 Biotech Inc. | -5.98 Million USD | -238.178% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | 4.898% |
| Molecular Templates, Inc. | -8.12 Million USD | -149.274% |
| Navidea Biopharmaceuticals, Inc. | -15.17 Million USD | -33.431% |
| NexImmune, Inc. | -32.34 Million USD | 37.389% |
| Orgenesis Inc. | -55.36 Million USD | 63.42% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | 19.839% |
| Point of Care Nano-Technology, Inc. | -78.01 Thousand USD | -25857.163% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -10.723% |
| Scopus BioPharma Inc. | -11.6 Million USD | -74.43% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 96.465% |
| Statera Biopharma, Inc. | -174.4 Million USD | 88.389% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -464.409% |
| Trevena, Inc. | -40.28 Million USD | 49.736% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -35469.256% |
| Vicapsys Life Sciences, Inc. | -1.18 Million USD | -1613.12% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | 60.337% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -160.39% |